Thinly traded nano cap Chembio Diagnostics (NASDAQ:CEMI) jumps 54% premarket on average volume in reaction to the U.S. launch
of its rapid DPP COVID-19 point-of-care blood test that detects IgM and
IgG antibodies to SARS-CoV-2 in 15 minutes from a fingerstick sample.
https://seekingalpha.com/news/3557093-chembio-launches-rapid-covidminus-19-blood-test-shares-up-54-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.